Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria
Conclusions: Our findings suggest ACEIs as a relatively more renoprotective and safer treatment as compared to ARBs. Captopril and irbesartan may be inferior to the other ACEIs and ARBs respectively.Kidney Blood Press Res 2017;42:358 –368
Source: Kidney and Blood Pressure Research - Category: Urology & Nephrology Source Type: research
More News: Avapro | Captopril | Diabetes | Endocrinology | Kidney Transplant | Kidney Transplantation | Proteinuria | Study | Transplants | Urology & Nephrology